Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-20-000004

Options or other derivatives

  • Chief Financial Officer disposed of 650,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Spissinger Allan Horst Chief Financial Officer 2020-03-23 Other disposition · stock options −150,000 500,000 D: show line 1 in the form
Spissinger Allan Horst Chief Financial Officer 2020-03-23 Other disposition · stock options −200,000 300,000 D: show line 2 in the form
Spissinger Allan Horst Chief Financial Officer 2020-03-23 Other disposition · stock options −300,000 0 D: show line 3 in the form
Loading xslF345X03/primary_doc.xml…